Niacin–Statin Study Didn’t Give Desired Results: Stopped Early
The National Institutes of Health stopped a clinical trial studying a blood lipid treatment 18 months early. The study found that adding high dose, extended release niacin to statin treatment for patients with heart disease did not reduce cardiovascular events, such as heart attacks and strokes.
Study Participants
This study was referred to as AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglycerides: Impact on Global Health) and the 3414 participants were selected because they were at risk for cardiovascular events despite having a well controlled LDL cholesterol level. They were at increased risk due to a history of heart disease combined with low HDL cholesterol and high triglycerides. Low HDL levels and high triglycerides are both linked to increased risk of cardiovascular events.
Study participants were divided into two groups.
Continue reading ‘Niacin–Statin Study Didn’t Give Desired Results: Stopped Early’ »


Metamucil is a rich source of psyllium husk. Psyllium husk is a soluble fiber which works to lower LDL cholesterol levels.
